Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

General Cannabis Corp buy Medvey

Start price
€0.35
13.11.21 / 70%
Target price
€2.00
13.11.22
Performance (%)
-47.91%
End price
€0.18
14.11.22
Summary
This prediction ended on 14.11.22 with a price of €0.18. Massive losses of -47.91% were the result for the BUY prediction by Medvey. Medvey has 70% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
General Cannabis Corp - - -
iShares Core DAX® 1.280% 1.320% 13.605%
iShares Nasdaq 100 -2.457% -5.192% 25.941%
iShares Nikkei 225® -2.006% -1.389% 8.973%
iShares S&P 500 -0.662% -1.884% 23.684%

According to Medvey what are the pros and cons of General Cannabis Corp for the foreseeable future?

Pros
Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
Cons

Comments by Medvey for this prediction

In the thread General Cannabis Corp diskutieren

Buy General Cannabis Corp

Prediction Buy
Perf. (%) -47.91%
Target price 1.500
Change
Ends at

Kursziel gesetzt auf 1,5

Prediction Buy
Perf. (%) -47.91%
Target price 2.000
Change
Ends at 13.11.22

Kursziel geändert auf 2,0

In the thread Trading General Cannabis Corp
Prediction Buy
Perf. (%) -47.91%
Target price 2.000
Change
Ends at 13.11.22

Die von Medvey gewählte maximale Laufzeit wurde überschritten

Stopped prediction by Medvey for General Cannabis Corp

General Cannabis Corp

Start price
Target price
Perf. (%)
€0.071
22.07.23
€0.070
22.07.24
38.73%
23.07.24

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
buy
General Cannabis Corp

Start price
Target price
Perf. (%)
€0.16
08.12.22
€0.10
08.12.23
-54.49%
22.07.23

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
buy
General Cannabis Corp

Start price
Target price
Perf. (%)
€0.59
04.02.20
€0.70
04.11.21
-38.81%
05.11.21

Very Future proof/growth oriented business model
Leading role in innovation
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year